EP Patent

EP1678201A2 — Hydrochloride salts of a glycopeptide phosphonate derivative

Assigned to Innoviva Inc · Expires 2006-07-12 · 20y expired

What this patent protects

Disclosed are hydrochloride salts of telavancin having a chloride ion content of from about 2.4 wt. % to about 4.8 wt. %. The disclosed salts have improved stability during storage at ambient temperatures compared to other hydrochloride salts. Also disclosed are processes for pre…

USPTO Abstract

Disclosed are hydrochloride salts of telavancin having a chloride ion content of from about 2.4 wt. % to about 4.8 wt. %. The disclosed salts have improved stability during storage at ambient temperatures compared to other hydrochloride salts. Also disclosed are processes for preparing such salts.

Drugs covered by this patent

Patent Metadata

Patent number
EP1678201A2
Jurisdiction
EP
Classification
—
Expires
2006-07-12
Drug substance claim
No
Drug product claim
No
Assignee
Innoviva Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.